NewHydrogen Completes Construction and Commissioning of Its ThermoLoop® Engineering Test Unit

NewHydrogen completes test unit, but commercial impact remains years away and unproven.

What the company is saying

NewHydrogen, Inc. (OTCQB:NEWH) announces the completion and commissioning of its engineering test unit (ETU) for the ThermoLoop hydrogen production process. The company frames this as a foundational milestone, enabling demonstration of long duration stability and continuous cycling between hydrogen-producing reactions. The ETU is positioned as a bridge between laboratory experiments and the design of the first commercial pilot plant, with the goal of generating engineering data for scaling up. Ryan Patrick, Senior Chemical Engineer, is named as the leader of the ETU construction and ongoing operations, while CEO Steve Hill emphasizes the ETU’s role in defining pilot plant specifications. The narrative stresses the vast scale of the clean hydrogen market, referencing a Goldman Sachs estimate of $12 trillion in future market value and highlighting ThermoLoop’s intended industrial-scale capacity of 200,000 tonnes of hydrogen per year. The announcement is confident in tone, but all commercial and technical benefits are described as future outcomes contingent on successful pilot development.

What the data suggests

The only realised fact is the completion and commissioning of the ETU; no operational data, technical results, or performance metrics are disclosed. The company’s base case for an industrial-scale ThermoLoop system assumes a production capacity of 200,000 tonnes per year, equivalent to a 1.5 to 2 gigawatt electrolysis plant, but this is hypothetical and not tied to any current project. The release cites a $12 trillion future market value for clean hydrogen (Goldman Sachs) and notes that global installed electrolysis capacity was about 4 gigawatts in 2025, with project pipelines in the hundreds of gigawatts. No financial statements, revenue, cash position, or capital commitments are provided. The announcement does not present evidence of technical validation, pilot plant construction, or commercial agreements. All forward-looking claims—such as the ETU generating data for a pilot plant and the potential for industrial-scale deployment—remain unsubstantiated by disclosed results or contracts.

Analysis

The announcement’s tone is notably positive, emphasizing the completion of the engineering test unit (ETU) as a foundational milestone. However, the majority of key claims are forward-looking: the ETU is intended to generate data for a future commercial pilot plant, and the ultimate goal is an industrial-scale facility. No operational data, technical results, or financial metrics are disclosed to substantiate the ETU’s performance or the feasibility of scaling to commercial production. The narrative inflates the signal by referencing the vast potential market and the hypothetical scale of future plants, but these benefits are long-dated and contingent on multiple future steps. The capital intensity is high, as the envisioned industrial-scale plant would require major investment, yet no immediate earnings or commercial impact is presented. The gap between narrative and evidence is significant: while the ETU’s completion is real, all commercial and financial benefits remain speculative.

Risk flags

• ●Execution risk is high: the company must translate ETU data into a viable pilot plant, then scale to industrial production, each step requiring technical success and major capital investment. No evidence is provided that the ThermoLoop process can operate reliably or economically at scale.
• ●Commercialization risk is material: there are no disclosed offtake agreements, customer commitments, or funding for pilot or industrial plants. The addressable market is large, but the company’s ability to capture any share remains unproven.
• ●Disclosure risk is present: the announcement lacks operational data, technical validation, and financial details, making it difficult for investors to assess progress, capital needs, or competitive positioning. The use of large market estimates without company-specific achievements may inflate expectations.

Bottom line

NewHydrogen’s announcement marks the completion of its engineering test unit, a necessary but early technical milestone. No operational, financial, or commercial data are provided to support claims of process stability or readiness for pilot-scale deployment. The company’s narrative focuses on the vast $12 trillion clean hydrogen market and a hypothetical 200,000 tonne per year plant, but these remain distant goals with no disclosed path to realization. Investors have no visibility into technical performance, capital requirements, or commercial traction. The most important takeaway is that while the ETU is now operational, all value creation depends on future pilot plant success and subsequent industrial scaling—both of which are years away and carry substantial execution and commercialization risk. The next actionable update would require disclosure of technical results, pilot plant funding, or binding commercial agreements.

Announcement summary

(OTCQB:NEWH) NewHydrogen, Inc. announced the completion of construction and commissioning of its engineering test unit (ETU), enabling the company to demonstrate long duration stability of its ThermoLoop process. The ETU is designed to generate the engineering data required to design NewHydrogen’s first commercial pilot plant. The ETU allows for continuous cycling between the hydrogen-producing oxidation reaction and the reduction reaction, ultimately resulting in oxygen production. Ryan Patrick, Senior Chemical Engineer at NewHydrogen, led the ETU construction and oversees its operation. The company states that continuous operation of the ETU will provide data to determine specifications for the first commercial pilot plant. The ETU serves as a bridge between bench-scale laboratory experiments and the commercial pilot plant, characterizing process performance and kinetics of ThermoLoop under continuous, repeatable conditions. This milestone follows a previous announcement regarding automation of the ETU’s controls to enable continuous testing with greater precision and repeatability. With the ETU now operational, NewHydrogen will use data from long duration operation to define specifications for its first commercial pilot plant. The company notes that a successful pilot plant will provide the basis for an industrial-scale ThermoLoop facility to meet clean hydrogen market needs. Clean hydrogen demand is now measured in gigawatts, with industrial-scale systems defined as 1 gigawatt or greater. Worldwide installed electrolysis capacity totaled about 4 gigawatts in 2025, distributed across many small and mid-sized projects. Announced project pipelines have reached into the hundreds of gigawatts. ThermoLoop is designed to address this gap, with NewHydrogen’s industrial-scale base case system assuming production capacity of 200,000 tonnes of hydrogen per year (200 ktpa). This scale is equivalent to a 1.5 to 2 gigawatt dedicated electrolysis plant or a large commercial steam methane reforming facility. The current market for hydrogen relies on fossil fuel feedstock, but ThermoLoop uses heat to split water and produce clean hydrogen. Steve Hill, CEO of NewHydrogen, stated that the ETU is foundational for future developments, enabling continuous cycling and data generation for pilot plant design. The company is working with a research team at UC Santa Barbara. Goldman Sachs has estimated the future market value of the clean hydrogen economy at $12 trillion.

Disagree with this article?